Medicine

UCI breaks ground on new hospital, medical complex in Irvine

New facility on campus will be next chapter of healthcare in Orange County

Dr. Steve Goldstein

UCI is among founding members of national coalition to improve clinical trials

ACT@POC aims to boost efficiency, accessibility and participant diversity to benefit patients

Dr. Virginia Kimonis

UCI and CHOC join new NORD Rare Disease Centers of Excellence Network

Partnership is committed to improving access and care for rare disease patients

Busola Oladeru gets her coat put on by Dean Hirsch.

Pharm.D. 41 make UCI history

Inaugural class welcomed at White Coat Ceremony

(From left: Michael J. Stamos, dean of the UCI School of Medicine, and Ethan Wayne, John Wayne Cancer Foundation director.)

John Wayne Cancer Foundation gift establishes new surgical oncology fellowship training program at UCI

Endowed medical chair, fellowship will expand research, teaching and service activities

UCI receives 5-year, $5 million CIRM award for training of diverse researchers

Program will prepare leaders in stem cell biology, gene therapy and regenerative medicine

UCI Chancellor Howard Gillman, Prof. Robert A. Mah, Dr. Adeline Yen Mah and and UCI Vice Chancellor for Health Affairs Steve A.N. Goldstein

Falling Leaves Foundation $30 million lead gift to fund innovative UCI medical research building

Facility to be designed to advance cross-disciplinary teaching, translational research activities

UCI virologist Michael Buchmeier

What you need to know about the delta variant

UCI coronavirus expert Michael Buchmeier answers your questions

Philip Felgner, UCI professor in residence of physiology & biophysics and director of the campus’s Vaccine Research and Development Center

UCI professor wins Spain’s prestigious Princess of Asturias award for scientific research

Philip Felgner is one of seven honored for contributions to designing COVID-19 vaccines

T regulatory cells (green with red nuclei) interact with antigen-presenting cells (magenta) in a tumor (blue). The Treg cell on top is activated (green fluorescence in the nucleus), while the one at the bottom is not (green fluorescence outside the nucleus). Activation of Treg cells promotes tumor growth.

UCI-led study finds that cancer immunotherapy may self-limit its efficacy

Common tumor inhibitor drug triggers favorable and unfavorable immune effects